Evidence of a threshold dose for promotion of hepatocarcinogenesis by hexachlorobenzene in a rat medium-term liver bioassay

Journal of Toxicologic Pathology

Volumn 18, Issue 1, 2005, Pages 7-11

  Ichihara, Toshio ^a,b   Imai, Norio ^a,b   Toda, Yosuke ^b   Hagiwara, Akihiro ^b   Tamano, Seiko ^b   Shirai, Tomoyuki ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^b Daiyukai Research Institute for Medical Science   (Japan)

Author keywords

Hepatocarcinogenesis; Hexachlorobenzene; Medium term bioassay system; Promotion

Indexed keywords

EID: 27444437206     PISSN: 09149198     EISSN: None     Source Type: Journal    
DOI: 10.1293/tox.18.7     Document Type: Article

References (25)

1. Meijer SN, Ockenden WA, Sweetman A, Breivik K, Grimalt JO, and Jones KC. Global distribution and budget of PCBs and HCB in background surface soils: implications for sources and environmental processes. Environ Sci Technol. 37: 667-672. 2003.
2. McGovern V. Hexachlorobenzene exposure: widespread toxicant produces pervasive effects. Environ Health Perspect. 112: A416. 2004.
3. Sala M, Ribas-Fito N, Cardo E, de Muga ME, Marco E, Mazon C, Verdu A, Grimalt JO, and Sunyer J. Levels of hexachlorobenzene and other organochlorine compounds in cord blood: exposure across placenta. Chemosphere. 43: 895-901. 2001.
4. Delgado IF, Barretto HH, Kussumi TA, Alleluia IB, Baggio Cde A, and Paumgartten FJ. Serum levels of organochlorine pesticides and polychlorinated biphenyls among inhabitants of Greater Metropolitan Rio de Janeiro, Brazil. Cad Saude Publica. 18: 519-524. 2002.
5. Charlier C, Foidart JM, Pitance F, Herman P, Gaspard U, Meurisse M, and Plomteux G. Environmental dichlorodiphenyltrichlorethane or hexachlorobenzene exposure and breast cancer: is there a risk? Clin Chem Lab Med. 42: 222-227. 2004.
6. Peters HA. Hexachlorobenzene poisoning in Turkey. Fed Proc. 35: 2400-2403. 1976.
7. Gocmen A, Peters HA, Cripps DJ, Morris CR, and Dogramaci I. Porphyria turcica: hexachlorobenzene-induced porphyria. IARC Sci Publ. 567-573. 1986.
8. Grimalt JO, Sunyer J, Moreno V, Amaral OC, Sala M, Rosell A, Anto JM, and Albaiges J. Risk excess of soft-tissue sarcoma and thyroid cancer in a community exposed to airborne organochlorinated compound mixtures with a high hexachlorobenzene content. Int J Cancer. 56: 200-203. 1994.
9. Cabral JR and Shubik P. Carcinogenic activity of hexachlorobenzene in mice and hamsters. IARC Sci Publ. 411-416. 1986.
10. Rockville MD. SARoCS Hexachlorobenzene CAS no. 118-74-1. Department of Health and Human Services. 223-226. 1994.
11. Arnold DL, Moodie CA, Collins BT, Zawidzka ZZ, and Krewski DR. Two-generation chronic toxicity study with hexachlorobenzene in the rat. IARC Sci Publ. 405-410. 1986.
12. Cabral R, Hoshiya T, Hakoi K, Hasegawa R, and Ito N. Medium-term bioassay for the hepatocarcinogenicity of hexachlorobenzene. Cancer Lett. 100: 223-226. 1996.
13. Shirai T. A medium-term rat liver bioassay as a rapid in vivo test for carcinogenic potential: a historical review of model development and summary of results from 291 tests. Toxicol Pathol. 25(5): 453-460. 1997.
14. Shirai T, Hirose M, and Ito N. Medium-term bioassays in rats for rapid detection of the carcinogenic potential of chemicals. In: DB McGregor, JM Rice and S Venitt (eds.), The Use of Short- and Medium-term Tests for Carcinogens and Data on Genetic Effects in Carcinogenic Hazard Evaluation. International Agency for Research on Cancer, Lyon, vol. IARC Scientific Publications No. 146, 251-272, 1999.
15. Ito N, Tamano S, and Shirai T. A medium-term rat liver bioassay for rapid in vivo detection of carcinogenic potential of chemicals. Cancer Sci. 94: 3-8. 2003.
16. International Conference on Harmonization of Technical Requirements for the Registration of Pharmaceuticals for Human Use. Testing for Carcinogenic Activity, 1995.
17. Pitot H and Dragan Y. Chemical carcinogenesis. In: CD Klaassen (ed.), Casarett & Doull's TOXICOLOGY The Basic Science of Poisons. McGraw-Hill, 2001: vol. 8, 241-319.
18. Tiwawech D, Hasegawa R, Kurata Y, Tatematsu M, Shibata MA, Thamavit W, and Ito N. Dose-dependent effects of 2 acetylaminofluorene on hepatic foci development and cell proliferation in rats. Carcinogenesis. 12: 985-990. 1991.
19. Hasegawa R, Takahashi S, Shirai T, Iwasaki S, Kim DJ, Ochiai M, Nagao M, Sugimura T, and Ito N. Dosedependent formation of preneoplastic foci and DNA adducts in rat liver with 2-amino-3-methyl-pH- pyrido[2,3-b]indole (MeAαC) and 2-amino-1 methyl-6- phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis. 13: 1427-1431. 1992.
20. Kitano M, Ichihara T, Matsuda T, Wanibuchi H, Tamano S, Hagiwara A, Imaoka S, Funae Y, Shirai T, and Fukushima S. Presence of a threshold for promoting effects of phenobarbital on diethylnitrosainine-induced hepatic foci in the rat. Carcinogenesis. 19: 1475-1480. 1998.
21. Kishima MO, Barbisan LF, Estevao D, Rodrigues MA, and Viana de Camargo JL. Promotion of hepatocarcinogenesis by hexachlorobenzene in energy-restricted rats. Cancer Lett. 152: 37-44. 2000.
22. Smith AG and Cabral JR. Liver-cell tumours in rats fed hexachlorobenzene. Cancer Lett. 11: 169-172. 1980.
23. Smith AG, Francis JE, Dinsdale D, Manson MM, and Cabral JR. Hepatocarcinogenicity of hexachlorobenzene in rats and the sex difference in hepatic iron status and development of porphyria. Carcinogenesis. 6: 631-636. 1985.
24. Stewart FP, Manson MM, Cabral JR, and Smith AG. Hexachlorobenzene as a promoter of diethylnitrosamineinitiated hepatocarcinogenesis in rats and comparison with induction of porphyria. Carcinogenesis. 10: 1225-1230. 1989.
25. Ito N, Hasegawa I, Imaida K, Hirose M, Shirai T, Tamano S, and Hagiwara A. Medium-term rat liver bioassay for rapid detection of hepatocarcinogenic substances. J Toxicol Pathol. 10: 1-11. 1997.